Home Up Feedback Contents Search Sell your Prod. Meet us News           

 
Home • Up • VEGF antibodies

Functional anti

 

Home
VEGF antibodies

GENTAUR

+32 1658 9045

or

0032 (0)16 41 44 07

+32 1650 9045

info@gentaur.com

Av. de l' Armée 68

B-1040 Brussels

BELGIUM

France

tel 01 43 25 01 50

fax01 43 25 01 60

9, rue Lagrange

75005 Paris

Italia

tel 02 36 00 65 93

fax 02 36 00 65 94

20135 Milano

Deutschland

tel +32 1658 9045

fax +32 1650 9045

Polska

Tel 058 710 33 44

Fax 00 32 16 50 90 45

ul. Grunwaldzka 88A/2

81-771 Sopot

日本

tel +81 78 386 0860

fax +81 78 306 0296

Minaatojimaminami-manchi

Chuo-ku, Kobe

065-0047

Österreich
+43720880899

Canada Montreal
+15149077481

Česká republika Praha
+420246019719

Danmark
+4569918806

Finland Helsset
+358942419041

Ελλάς Αθήνα
+302111768494

Magyarország Budapest
+3619980547

Ireland Dublin
+35316526556

Luxembourg
+35220880274

Nederland
+31208080893

Norge Oslo
+4721031366

Polska Warszawa
+48223988221

Sverige Stockholm
+46852503438

Schweiz Züri
+41435006251

US New York
+17185132983

Other Countries
0032 (0)16 41 44 07


 

 

 

 

 

Clonagen

Gentaur

Genprice

Bioxys

Labprice

FUNCTIONAL ANTIBODIES CONVENTIONAL ABS

List of Agonistic Antibodies

Antibody Name Catalogue Number Unit Size/Price

Agonistic Human VEGFR2 pV1001g-h 50mg/299€ + 85€ handling

(Polyclonal Ab)

Agonistic Human VEGFR2 mV1001.3m-h 200mg/399€ + 85€ handling

(Monoclonal Ab)

Agonistic Mouse VEGFR2 mV1001r-m 200mg/399€ + 85€ handling

(Monoclonal Ab)

Agonistic Human VEGFR1 mV1004m-h 200mg/399€ + 85€ handling

(Monoclonal Ab)

List of Antagonistic/Blocking Antibodies

Antibody Name Catalogue Number Unit Size/Price

Antagonistic Mouse PECAM-1 mP1001r-m 200mg/399€ + 85€ handling

(Monoclonal Ab)

Antagonistic Human VEGFR2 mV1001.1m-h 200mg/399€ + 85€ handling

(Monoclonal Ab)

Antagonistic Human VEGFR1 pV1004R-h 100mg/249€ + 85€ handling

(Polyclonal Ab)

Antagonistic Human Endoglin mT1001m-h 200mg/399€ + 85€ handling

(monoclonal Ab)

Blocking Antibody of Mouse PlGFNew mP1002r-m 200mg/399€ + 85€ handling

(monoclonal Ab)

 
human Activin A 100-310 5 210 14 anti-human CTGFL, pab 102-P110 100 270 26
human Adiponection 100-121 25 210 14 anti-mouse CTLA4, pab 103-P43 100 270 26
human AITRL 100-122 20 210 14 human CXCL16 100-148 25 210 27
human Ang-1 300-047 5 90 14 anti-human CXCL16, pab 100-P111 100 270 27
human Ang-1 300-048 20 265 14 mouse CXCL16 M10-056 25 210 27
human Ang-2 300-049 5 90 15 anti-mouse CXCL16, pab 103-P44 100 270 27
human Ang-2 300-050 20 245 15 human CYR61 100-149 20 210 27
human ApoA-I 100-123 100 210 15 bovine ECGF (Crude Extract) 300-090 15mg 70 208
human ApoE2 100-124 500 210 15 porcine ECGF (Crude Extract) 300-092 15mg 70 209
human ApoE3 100-125 500 210 15 human EGF 100-008 100 55 27
human ApoE4 100-126 500 210 16 human EGF 100-009 500 135 27
human Apo-SAA 100-127 500 210 16 anti-human EGF, pab 102-P06 100 270 28
mouse APRIL M10-050 20 210 16 mouse EGF M10-002 100 90 27
anti-human APRIL, pab 102-P210 100 270 16 mouse EGF M10-003 500 210 27
human Artemin 100-128 20 210 16 anti-mouse EGF, pab 103-P45 100 270 28
human 4-1BB receptor S01-039 20 210 17 human EG-VEGF 100-150 20 210 28
anti-human 4-1BB receptor, pab 102-P100 100 270 17 anti-human EG-VEGF, pab 102-P113 100 270 28
human 4-1BBL 100-001 20 210 17 human EMAP-II 100-010 20 210 28
anti-mouse B71, pab 103-P40 100 270 17 anti-human EMAP-II, pab 102-P114 100 270 28
human BAFF 100-002 20 210 18 human ENA-78/LIX 100-011 20 210 29
anti-human BAFF, mab 101-M18 500 250 18 anti-human ENA-78, pab 102-P07 100 270 29
anti-human BAFF, pab 102-P101 100 270 18 human Eotaxin-2 100-013 20 210 29
human sBAFF receptor S01-038 50 210 18 anti-human Eotaxin-2, mab 101-M01 500 250 29
human BCA-1 100-003 20 270 19 anti-human Eotaxin-2, pab 102-P09 100 270 29
anti-human BCA-1, pab 102-P01 100 210 19 mouse Eotaxin-2 M10-059 20 270 29
mouse BCA-1 M10-051 20 210 19 anti-mouse Eotaxin-2, pab 103-P48 100 210 29
human BCMA 100-131 5 210 19 human Eotaxin-3 100-014 20 210 30
human BD-1 (36aa) 100-132 20 210 19 anti-human Eotaxin-3, mab 101-M19 500 250 30
human BD-1 (47aa) 100-133 20 210 19 anti-human Eotaxin-3, pab 102-P10 100 270 30
anti-human BD2, pab 102-P103 100 270 20 human Exodus-2 100-015 20 210 30
human BD-2 100-004 20 210 19 anti-human Exodus-2, pab 102-P11 100 270 30
human BD-3 100-135 20 210 19 mouse Exodus-2 M10-005 20 210 30
human BDNF 100-005 10 210 20 anti-mouse Exodus-2, pab 103-P03 100 270 30
anti-human BDNF, pab 102-P02 100 270 20 human sFAS Ligand 100-157 10 210 31
human sBMP receptor-1A S01-021 100 285 21 anti-human sFAS Ligand, pab 102-P120 100 270 31
human BMP-2 200-001 5 90 20 human sFAS receptor S01-030 20 210 31
human BMP-2 200-002 25 350 20 human FGF-acidic 100-016 50 210 31
anti-human BMP-2/4, pab 102-PA90S 100 150 21 anti-human FGF-acidic, pab 102-P12 100 270 32
anti-human BMP-2/4, pab 102-PA90 200 225 21 human FGF-2 (basic) 300-001 10 80 32
anti-human BMP-2, pab 102-P03A 100 270 20 human FGF-2 (basic) 300-002 25 100 32
anti-human BMP-7, pab 102-P105 100 270 21 human FGF-2 (basic) 300-003 50 175 32
human BMP-13 100-137 50 210 21 anti-human FGF-2 (basic), pab 102-PA08S 100 150 32
human BRAK 100-139 20 210 22 anti-human FGF-2 (basic), pab 102-PA08 200 225 32
mouse mouse C-10 M10-001 10 210 22 anti-human FGF-2 (basic), mab 101-M70 500 250 32
anti-mouse anti-mouse C-10, pab 103-P01 100 270 22 anti-human FGF-2 (basic), pab 102-P13 100 270 32
human Cardiotrophin-1 100-140 10 210 22 human FGF-4 100-017 25 210 33
mouse Cardiotrophin-1 M10-052 10 210 22 human FGF-5 100-018 50 210 33
anti-human Cardiotrophin-1, pab 102-P04 100 270 23 anti-human FGF-5, mab 101-M71 500 250 34
human sCD105/Endoglin S01-024 5 75 24 human FGF-6 100-019 25 210 33
human sCD105/Endoglin S01-025 25 280 24 human FGF-7/KGF 100-163 10 210 34
anti-human sCD105/Endoglin, pab 102-PA60S 100 150 24 anti-human FGF-7/KGF, pab 102-P123 100 270 34
anti-human sCD105/Endoglin, pab 102-PA60 200 225 24 human FGF-8 100-020 25 210 33
anti-human sCD105/Endoglin, pab 102-PA60AG 50 210 24 human FGF-9 100-021 20 210 33
mouse sCD105/Endoglin S01-022 5 75 24 human FGF-9 300-007 5 80 33
mouse sCD105/Endoglin S01-023 25 280 24 human FGF-9 300-008 20 175 33
anti-mouse sCD105/Endoglin, mab 103-M60 100 230 24 mouse FGF-9 M10-006 10 210 33
anti-mouse sCD105/Endoglin, mab 103-MBi60 50 250 24 anti-mouse FGF-9, pab 103-P04 100 270 33
anti-mouse sCD105/Endoglin, pab 103-PA60S 100 150 24 human FGF-10 100-022 25 210 33
anti-mouse sCD105/Endoglin, pab 103-PA60 200 225 24 anti-human FGF-10, pab 102-P124 100 270 34
anti-mouse sCD105/Endoglin, pab 103-PA60AG 50 210 24 human FGF-16 100-023 25 210 33
human sCD22 S01-031 20 210 23 anti-human FGF-16, pab 102-P125 100 270 34
anti-human sCD22, pab 102-P107 100 270 23 human FGF-17 100-024 25 210 33
anti-human sCD40 Ligand, pab 102-P108 100 270 23 anti-human FGF-17, pab 102-P126 100 270 34
anti-human sCD40 Ligand, pab 102-P108G 100 270 23 human FGF-18 100-025 25 210 33
mouse sCD40 Ligand/TRAP M10-54 25 210 23 human FGF-19 100-169 25 210 33
human sCD40 Ligand/TRAP 100-115 50 210 23 human FGF-20 100-170 15 210 33
human CNTF 100-007 20 210 25 human sFGFR-1/Fc Chimera SFC-015 10 75 34
anti-human CNTF, pab 102-P05 100 270 25 human sFGFR-1/Fc Chimera SFC-016 50 235 34
rat CNTF R20-001 25 210 25 human sFGFR-2/Fc Chimera SFC-017 10 75 34
anti-rat CNTF, pab 104-P01 100 270 25 human sFGFR-2/Fc Chimera SFC-018 50 235 34
human CRP 100-144 10 210 25 human sFGFR-3/Fc Chimera SFC-019 10 75 34
human CTACK 100-145 20 210 25 human sFGFR-3/Fc Chimera SFC-020 50 235 34
mouse CTACK M10-055 20 210 25 human sFGFR-4/Fc Chimera SFC-021 10 75 35
human CTGF (98aa) 100-146 20 210 26 human sFGFR-4/Fc Chimera SFC-022 50 235 35
human CTGFL 100-147 20 210 26 human flt3-Ligand 100-026S 2 55 35

human flt3-Ligand 100-026 10 135 35 anti-human IGF-1, pab 102-P28 100 270 46
human flt3-Ligand 100-026-SC 50 375 35 mouse IGF-1 M10-011 50 210 46
anti-human flt3-Ligand, pab 102-P14 100 270 35 anti-mouse IGF-1, pab 103-P08 100 270 46
mouse flt3-Ligand M10-062 10 210 35 human IGF-2 100-041 50 210 46
human Follistatin 100-172 20 210 36 anti-human IGF-2, pab 102-P29 100 270 46
human Fractalkine (CX3C) 100-173 20 210 36 human IGF-BP1 100-197 25 210 47
anti-human Fractalkine, pab 102-P15 100 270 36 human IGF-BP2 100-198 25 210 47
human gAcrp30 100-174 25 210 36 human IGF-BP3 100-199 25 210 47
anti-human gAcep 30, pab 102-P129 100 270 37 anti-human IGF-BP-3, pab 102-P144 100 270 47
human gAcrp30 Variant 100-174a 25 210 36 human IGF-BP4 100-200 25 210 47
anti-human gAcep 30 Variant, pab 102-P130 100 270 37 human IGF-BP5 100-201 25 210 47
mouse gAcrp30 M10-063 25 210 36 human IGF-BP6 100-202 25 210 47
human Galectin-1 100-175 50 210 37 human IGF-BP7 100-203 25 210 47
anti-human Galectin-1, pab 102-P131 100 270 37 human IL-1 alpha 100-042 10 210 47
human Galectin-3 100-176 50 210 37 anti-human IL-1 alpha, pab 102-P30 100 270 48
human GCP-2 100-028 20 210 38 mouse IL-1 alpha M10-012 10 210 47
anti-human GCP-2, pab 102-P16 100 270 38 anti-mouse IL-1 alpha, pab 103-P10 100 270 48
human G-CSF 100-029 10 160 38 rat IL-1 alpha R20-024 10 210 47
anti-human G-CSF, pab 102-P17 100 270 38 anti-rat IL-1 alpha, pab 104-P22 100 270 48
mouse G-CSF M10-007 10 210 38 human IL-1 beta 400-001 2 55 48
anti-mouse G-CSF, pab 103-P05 100 270 38 human IL-1 beta 400-002 10 135 48
human GDF-3 100-179 20 210 39 human IL-1 beta 400-002-DC 50 395 48
human GDF-9 100-180 20 210 39 anti-human IL-1 beta, mab 101-M03 500 250 48
human GDF-11 100-181 20 210 39 anti-human IL-1 beta, pab 102-P31 100 270 48
human GDNF 100-030 10 210 40 mouse IL-1 beta M10-013 10 210 48
anti-human GDNF, pab 102-P18 100 270 40 anti-mouse IL-1 beta, pab 103-P11 100 270 48
human GM-CSF 200-004 2 55 40 rat IL-1 beta R20-005 10 210 48
human GM-CSF 200-005 10 135 40 anti-rat IL-1 beta, pab 104-P04 100 270 48
human GM-CSF 200-005-DC 50 375 40 human IL-1 receptor antagonist 100-043 20 210 49
human GM-CSF 400-010 2 65 40 human IL-2 200-009 5 70 49
human GM-CSF 400-010S 5 120 40 human IL-2 200-010 50 175 49
human GM-CSF 400-011 20 320 40 anti-human IL-2, mab 101-M04 500 250 49
human GM-CSF 400-011-DC 50 425 40 anti-human IL-2, pab 102-P148 100 270 49
anti-human GM-CSF, pab 102-P19 100 270 41 anti-human IL-2, pab 102-P32 100 270 49
mouse GM-CSF M10-008 10 210 40 mouse m IL-2 M10-014 20 210 49
anti-mouse GM-CSF, pab 103-P06 100 270 41 anti-mouse IL-2, pab 103-P12 100 270 49
rat GM-CSF R20-041 10 210 40 rat IL-2 R20-026 20 210 49
human GRO/MGSA 100-031 25 210 41 human h sIL-2 receptor S01-032 25 210 50
anti-human GRO/MGSA, pab 102-P20 100 270 41 human IL-3 200-015 2 55 50
human GRO-beta 100-032 10 210 41 human IL-3 200-015-SC 50 135 50
anti-human GRO-beta, pab 102-P21 100 270 41 human IL-3 200-016 10 375 50
human GRO-gamma 100-033 10 210 41 human IL-3 400-003S 2 60 50
anti-human GRO-gamma, pab 102-P22 100 270 41 human IL-3 400-003 5 90 50
rat GROß/MIP-2 R20-002 25 210 41 human IL-3 400-004 20 270 50
anti-rat GROß/MIP-2, pab 104-P02 100 270 41 human IL-3 400-004-SC 50 425 50
rat GRO/KC (CXCL1) R20-003 25 210 41 anti-human IL-3, pab 102-P33 100 270 51
anti-rat GROß/KC, pab 104-P20 100 270 41 mouse IL-3 M10-015 10 210 50
human HB-EGF 100-185 50 210 42 anti-mouse IL-3, pab 103-P13 100 270 51
human HCC-1 100-034 10 210 42 rat IL-3 beta R20-006 10 210 51
HeLa cells (5x10E9 cells) FER-001 240 211 anti-rat IL-3 beta, pab 104-P24 100 270 51
human Heregulin beta-1 100-187 50 210 42 human IL-4 200-021 2 55 51
human HGF 300-010 5 90 43 human IL-4 200-022 10 135 51
human HGF 300-011 25 350 43 human IL-4 200-023-DC 50 395 51
anti-human HGF, pab 102-PA62S 100 175 43 anti-human IL-4, mab 101-M05 500 250 51
anti-human HGF, pab 102-PA62 200 290 43 anti-human IL-4, pab 102-P34 100 270 51
anti-human HGF, pab 102-PA62AG 50 210 43 mouse IL-4 M10-016 10 210 51
anti His-tag, pab 102-PA80 50 120 210 anti-mouse IL-4, pab 103-P14 100 270 51
human I-309 100-035 10 210 43 rat IL-4 R20-007 10 210 51
anti-human I-309, pab 102-P24 100 270 43 anti-rat IL-4, pab 104-P05 100 270 51
human IFN-alpha 100-036 100 210 44 human sIL-4 receptor alpha S01-033 15 210 52
anti-human IFN-alpha, mab 101-M02 500 250 44 human IL-5 100-044 10 210 52
anti-human IFN-alpha, pab 102-P25 100 270 44 anti-human IL-5, pab 102-P35 100 270 52
human IFN-beta 100-037 10 210 44 human IL-6 200-030 2 45 52
human IFN-beta 100-191 10 210 44 human IL-6 200-031 20 135 52
anti-human IFN-beta, pab 102-P26 100 270 44 human IL-6 200-030-DC 50 375 52
human h IFN-gamma 100-039 100 210 45 anti-human IL-6, mab 101-M06 500 250 53
anti-human IFN-gamma, pab 102-P27 100 270 45 anti-human IL-6, pab 102-P153 100 270 53
mouse IFN-gamma M10-010 100 210 45 anti-human IL-6, pab 102-P36 100 270 53
anti-mouse IFN-gamma, pab 103-P07 100 270 45 mouse IL-6 M10-017 10 210 52
rat IFN-gamma R20-004 100 210 45 anti-mouse IL-6, pab 103-P15 100 270 53
anti-rat IFN-gamma, pab 104-P03 100 270 45 rat IL-6 R20-008 10 210 52
human IFN-lambda1 100-193 20 210 45 anti-rat IL-6, pab 104-P06 100 270 53
human IFN-lambda2 100-194 20 210 45 anti-rat IL-6, pab 104-P27 100 270 53
mouse IFN-lambda2 M10-068 20 210 45 human sIL-6 receptor alpha S01-034 20 210 53
human IGF-1 100-040 100 210 46 human IL-7 100-045 10 210 53

anti-human IL-7, mab 101-M07 500 250 54 anti-human LEC/NCC-4 102-P51 100 270 63
anti-human IL-7 102-P37 100 270 53 human Leptin 100-061 1000 210 64
mouse IL-7 M10-018 10 210 53 anti-human Leptin, mab 101-M74 500 250 64
anti-mouse IL-7, pab 103-P16 100 270 54 anti-human Leptin, pab 102-P52 100 270 64
rat IL-7 R20-029 10 210 53 mouse Leptin M10-028 1000 210 64
human IL-8 (72aa) 100-046 25 210 54 anti-mouse Leptin, pab 103-P24 100 270 64
human IL-8 (77aa) 100-047 25 210 54 rat Leptin R20-033 1000 210 64
anti-human IL-8, mab 101-M08 500 250 54 anti-rat Leptin, pab 104-P29 100 270 64
anti-human IL-8, pab 102-P38 100 270 54 mouse LIGHT M10-076 20 210 64
human IL-9 100-217 10 210 55 anti-human LIGHT, pab 102-P172 100 270 64
anti-human IL-9, pab 102-P155 100 270 55 mouse LIX/CXCL5 (70 aa) M10-030 20 210 29
mouse IL-9 M10-069 10 210 55 mouse LIX/CXCL5 (93 aa) M10-114 20 210 29
anti-mouse IL-9, pab 103-P57 100 270 55 anti-mouse LIX, pab 103-P26 100 270 29
human IL-10 100-049 10 210 55 human Lymphotactin 100-063 20 210 65
anti-human IL-10, pab 102-P40 100 270 55 anti-human Lymphotactin, pab 102-P54 100 270 65
mouse IL-10 M10-020 10 210 55 human sLYVE-1 S01-028 5 75 65
anti-mouse IL-10, pab 103-P18 100 270 55 human sLYVE-1 S01-029 25 280 65
rat IL-10 R20-009 10 210 55 anti-human Lyve-1, pab 102-PA50S 100 175 65
anti-rat IL-10, pab 104-P07 100 270 55 anti-human Lyve-1, pab 102-PA50 200 290 65
human IL-11 100-050 10 210 56 anti-human Lyve-1, pab 102-PA50AG 50 210 66
anti-human IL-11, mab 101-M09 500 250 56 anti-human Lyve-1, pab 102-PABi50 50 210 66
anti-human IL-11, pab 102-P41 100 270 56 mouse sLYVE-1 S01-026 5 75 65
human IL-12 100-051 10 210 56 mouse sLYVE-1 S01-027 25 280 65
anti-human IL-12, mab 101-M72 500 250 57 anti-mouse Lyve-1, pab 103-PA50S 100 175 65
anti-human IL-12, pab 102-P42 100 270 56 anti-mouse Lyve-1, pab 103-PA50 200 290 65
mouse IL-12 M10-021 10 210 56 anti-mouse Lyve-1, pab 103-PA50AG 50 210 66
anti-mouse IL-12, mab 103-M23 500 250 57 anti-mouse Lyve-1, pab 103-PABi50 50 210 66
anti-mouse IL-12, pab 103-P19 100 270 56 human MCP-1 (MCAF) 100-065 20 210 67
human IL-12p40 100-311 10 210 57 anti-human MCP-1, mab 101-M12 500 250 67
mouse IL-12p40 M10-070 10 210 57 anti-human MCP-1/MCAF, pab 102-P55 100 270 67
human IL-13 100-052 10 210 57 rat MCP-1 (MCAF) R20-010 10 210 67
anti-human IL-13, pab 102-P43 100 270 57 anti-rat MCP-1/MCAF, pab 104-P08 100 270 67
mouse IL-13 M10-071 10 210 57 human MCP-2 100-066 10 210 67
anti-mouse IL-13, pab 103-P60 100 270 57 anti-human MCP-2, mab 101-M75 500 250 67
rat IL-13 R20-031 10 210 57 anti-human MCP-2, pab 102-P56 100 270 67
human IL-15 100-053 10 210 58 mouse MCP-2 M10-075 20 210 67
anti-human IL-15, mab 101-M10 100 270 58 human MCP-3 100-067 10 210 67
anti-human IL-15, pab 102-P44 100 270 58 anti-human MCP-3, mab 101-M13 500 250 67
mouse IL-15 M10-022 10 210 58 anti-human MCP-3, pab 102-P177 100 270 67
rat IL-15 R20-032 10 210 58 anti-human MCP-3, pab 102-P57 100 270 67
human IL-16 100-054 10 210 58 mouse MCP-3 M10-031 10 210 67
anti-human a-h IL-16 102-P45 100 270 58 anti-mouse MCP-3, pab 103-P27 100 270 67
mouse IL-16 (130aa) M10-083 10 210 58 human MCP-4 100-068 10 210 67
human IL-17A 100-055 25 210 59 anti-human MCP-4, mab 101-M76 500 250 67
anti-human IL-17A, pab 102-P46 100 270 59 anti-human MCP-4, pab 102-P58 100 270 67
anti-human IL-17A, pab 102-P162 100 270 59 anti-human MCP-4, pab 102-P180 100 270 67
human IL-17B 100-225 25 210 59 mouse MCP-5 M10-032 20 210 67
human IL-17D 100-226 25 210 59 anti-mouse MCP-5, pab 103-P28 100 270 67
human IL-17E 100-227 10 210 59 human M-CSF 100-064S 2 55 66
anti-human IL-17E, pab 102-P163 100 270 60 human M-CSF 100-064 10 135 66
human IL-17F 100-228 10 210 60 anti-human M-CSF, pab 102-P60 100 270 66
anti-human IL-18BP, pab 102-P47 100 270 60 mouse M-CSF M10-078 10 210 66
human IL-19 100-229 10 210 60 anti-mouse M-CSF, pab 103-P63 100 270 66
human IL-20 100-230 10 210 60 human MDC (67 aa) 100-069 20 210 68
anti-human IL-20, pab 102-P165 100 270 61 human MDC (69 aa) 100-070 20 210 68
anti-human IL-22, pab 102-P166 100 270 61 anti-human MDC, mab 101-M77 500 250 68
mouse IL-22 M10-072 10 210 61 anti-human MDC, pab 102-P61 100 270 68
human IL-31 100-232 10 210 61 mouse MDC M10-033 20 210 68
mouse IL-31 M10-073 10 210 61 anti-mouse MDC, pab 103-P66 100 270 68
human IP-10 100-057 25 210 61 human MEC 100-246 20 210 68
anti-human IP-10, pab 102-P48 100 270 62 mouse MEC M10-090 20 210 68
mouse IP-10 M10-025 25 210 61 anti-mouse MECA32, mab 103-M42 100 230 68
anti-mouse IP-10, pab 103-P21 100 270 62 human MIA 100-247 20 210 69
human I-TAC 100-058 20 210 62 human Midkine 100-071 20 210 69
anti-human I-TAC, pab 102-P49 100 270 62 anti-human Midkine, pab 102-P183 100 270 69
mouse I-TAC/CXCL11 M10-086 20 210 62 human MIG 100-072 20 210 70
mouse JE (MCP-1) M10-026 100 210 67 anti-human MIG, mab 101-M78 500 250 70
anti-mouse JE (MCP-1), pab 103-P22 20 270 67 anti-human MIG, pab 102-P62 100 270 70
mouse KC (CXCL1) M10-027 20 210 41 mouse MIG M10-034 20 210 70
anti-mouse KC (CXCL1), pab 103-P23 100 270 41 human MIP-1 alpha 100-073 20 210 70
human LAG-1 100-234 20 210 62 anti-human MIP-1 alpha, mab 101-M14 500 250 71
human LD78beta/CCL3L1 100-235 20 210 63 anti-human MIP-1 alpha, pab 102-P63 100 270 71
anti-human LD78-beta, pab 102-P169 100 270 63 mouse MIP-1 alpha M10-035 10 210 70
human LEC/NCC-4 100-060 20 210 63 anti-mouse MIP-1 alpha, pab 103-P29 100 270 71
anti-human LEC, mab 101-M73 500 250 63 rat MIP-1 alpha R20-011 20 210 70
anti-rat MIP-1 alpha 104-P09 100 270 71 anti-human PlGF (nat), pab 102-PA04AG 50 180 82
human MIP-1 beta 100-074 10 210 71 anti-human Podoplanin, mab 101-M40 100 250 83
anti-human MIP-1 beta, pab 102-P64 100 270 71 anti-human Podoplanin Biotin, mab 101-MBi40 50 250 83
mouse MIP-1 beta M10-077 10 210 71 anti-human Podoplanin, pab 102-PA40S 100 175 83
rat MIP-1 beta R20-035 20 210 71 anti-human Podoplanin, pab 102-PA40 200 290 83
mouse MIP-1 gamma M10-036 20 210 72 anti-human Podoplanin, mab 103-M40 100 250 83
anti-mouse MIP-1 gamma, pab 103-P30 100 270 72 anti-human Podoplanin Biotin, mab 103-MBi40 50 250 83
mouse MIP-2 (CXCL2) M10-037 20 210 72 human Prokineticin-2 100-272 20 210 83
anti-mouse MIP-2/CXCL2, pab 103-P31 100 270 72 human Prolactin 100-273 20 210 84
human MIP-3 100-075 20 210 73 human Prox-1 (fragment) 300-052 5 70 84
anti-human MIP-3, pab 102-P66 100 270 73 anti-human Prox-1 (E,W,IF), pab 102-PA32S 100 150 84
anti-human MIP-3, pab 102-P66G 100 270 73 anti-human Prox-1 (E,W,IF), pab 102-PA32 200 225 84
human MIP-3 alpha 100-078 20 210 73 anti-human Prox-1 (E,W,IF), pab 102-PA32AG 50 175 84
anti-human MIP-3 alpha, mab 101-M79 500 250 73 anti-human Prox-1 (IHC), pab 102-PA30S 100 175 84
anti-human MIP-3 alpha, pab 102-P67 100 270 73 anti-human Prox-1 (IHC), pab 102-PA30 200 290 84
mouse MIP-3 alpha M10-100 20 210 73 human PTHrP 100-275 50 210 85
human MIP-3 beta 100-079 20 210 74 human sRANK receptor 100-117 20 210 86
anti-human MIP-3 beta, mab 101-M80 500 250 74 anti-human RANK receptor, pab 102-P206 100 270 86
anti-human MIP-3 beta, pab 102-P68 100 270 74 human sRANKL 100-276 10 210 85
mouse MIP-3 beta M10-079 20 210 74 anti-human sRANKL, mab 101-M82 500 250 85
anti-human MIP-4, pab 102-P69 100 270 74 anti-human sRANKL, pab 102-P204 100 270 85
human MIP-4 (PARC) 100-080 10 210 74 anti-human sRANKL, pab 102-P205 100 270 85
human MIP-5 100-081 25 210 75 mouse sRANKL M10-080 10 210 85
anti-human MIP-5, pab 102-P70 100 270 75 anti-mouse sRANKL, pab 103-P71 100 270 85
human Myostatin 100-255 10 210 75 human RANTES 100-095 20 210 86
human NAP-2 100-082 10 210 75 anti-human RANTES, mab 101-M16 500 250 86
anti-human NAP-2, mab 101-M81 500 250 76 anti-human RANTES, pab 102-P80 100 270 86
anti-human NAP-2, pab 102-P71 100 270 76 anti-mouse RANTES, pab 103-P32 100 270 86
anti-human NAP-2, pab 102-P191 100 270 76 anti-rat RANTES, pab 104-P10 100 270 86
human Neurturin 100-083 10 210 76 mouse RANTES M10-038 20 210 86
anti-human Neurturin, pab 102-P72 100 270 76 rat RANTES R20-012 20 210 86
human NGF-beta 100-084 20 210 76 human RELM alpha 100-279 20 210 87
anti-human NGF-beta, pab 102-P73 100 270 76 mouse RELM alpha M10-081 20 210 87
human NNT-1/BCSF-3 100-259 10 210 77 mouse RELM beta M10-082 20 210 87
human NOGGIN 100-260 20 210 77 anti-mouse RELM beta, pab 103-P50 100 270 87
human NP-1 100-085 20 210 77 human Resistin 100-280 25 210 87
anti-human NP-1, pab 102-P194 100 270 77 anti-human Resistin, pab 102-P92 100 270 88
human NT-3 100-086 10 210 78 mouse Resistin M10-084 25 210 87
anti-human NT-3, pab 102-P74 100 270 78 anti-mouse Resistin, pab 103-P51 100 270 88
anti-human NT-3, pab 102-P196 100 270 78 human SCF 100-097S 2 55 88
human NT-4 100-087 10 210 78 human SCF 100-097 10 135 88
anti-human NT-4, mab 101-M15 500 250 78 human SCF 100-097-SC 50 395 88
anti-human NT-4, pab 102-P75 100 270 78 human SCF 400-013S 2 65 88
anti-human NT-4, pab 102-P198 100 270 78 human SCF 400-013 5 120 88
human Oncostatin M 100-088 10 210 79 human SCF 400-014 20 320 88
anti-human Oncostain M, pab 102-P76 100 270 79 human SCF 400-014-SC 50 425 88
human Osteoprotegerin (OPG) 100-089 50 210 79 anti-human SCF, mab 101-M83 500 250 89
anti-human OPG, pab 102-P200 100 270 79 anti-human SCF, pab 102-P81 100 270 89
human PDGF-AA 200-051S 2 55 80 anti-human SCF, pab 102-P81G 100 270 89
human PDGF-AA 200-051 5 90 80 mouse SCF M10-039 10 210 88
human PDGF-AA 200-052 20 350 80 anti-mouse SCF, pab 103-P33 100 270 89
anti-human PDGF-AA, pab 102-P77 100 270 80 rat SCF R20-040 10 210 88
human PDGF-AB 200-053S 2 55 80 anti-rat SCF, pab 104-P30 100 270 89
human PDGF-AB 200-053 5 90 80 human SCGF-alpha 100-098 10 210 89
human PDGF-AB 200-054 20 350 80 anti-human SCGF-alpha, pab 102-P93 100 270 89
human PDGF-BB 200-055S 2 55 80 human SCGF-beta 100-096 10 210 89
human PDGF-BB 200-055 5 90 80 human SDF-1 alpha 100-099 10 210 89
human PDGF-BB 200-056 20 350 80 anti-human SDF-1 alpha, pab 102-P82 100 270 90
anti-human PDGF-BB, pab 102-P78 100 270 80 mouse SDF-1 alpha M10-040 10 210 89
human Persephin (PSP) 100-120 20 210 80 anti-mouse SDF-1 alpha, pab 103-P34 100 270 90
human PF-4 100-093 20 210 81 human SDF-1 beta 100-100 10 210 90
anti-human PF-4, pab 102-P79 100 270 81 anti-human SDF-1 beta, pab 102-P83 100 270 90
human Pleiotrophin 100-094 20 210 81 mouse SDF-1 beta M10-085 10 210 90
human PIGF-1 300-015S 2 80 81 mouse SF20 M10-092 10 210 90
human PIGF-1 300-015 5 160 81 human TACI 100-285 20 210 91
human PIGF-1 300-016 20 490 81 anti-human TACI, pab 102-P94 100 270 91
human PIGF-1/His 300-017S 2 70 81 human TARC 100-101 20 210 91
human PIGF-1/His 300-017 5 130 81 anti-human TARC, pab 102-P84 100 270 91
human PIGF-1/His 300-018 20 425 81 human TECK 100-102 20 210 92
human PIGF-2 300-019S 2 80 82 anti-human TECK, mab 101-M84 500 250 92
human PIGF-2 300-019 5 160 82 anti-human TECK, pab 102-P85 100 270 92
human PIGF-2 300-020 20 490 82 human TFF-1 100-288 20 210 92
anti-human PlGF, apb 102-PA01S 100 150 82 human TFF-2 100-289 20 210 92
anti-human PlGF, pab 102-PA01 200 225 82 human TGF-alpha 100-103 100 210 93
anti-human PlGF (nat), pab 102-PA04S 100 150 82 anti-human TGF-alpha, pab 102-P86 100 270 93

human TGF-beta1 300-023 5 210 93 anti-human VEGF-A, pab 102-PA02 200 225 104
anti-mouse TGF-beta1, mab 101-M85 100 250 93 anti-human VEGF-A, pab 102-PA03S 100 150 104
human TGF-beta2 100-105 5 210 94 anti-human VEGF-A, pab 102-PA03 200 225 104
human TGF-beta3 100-107 5 210 94 anti-mouse VEGF-A, pab 103-PA03S 100 150 104
human sTIE-1/Fc Chimera SFC-011 20 100 94 anti-mouse VEGF-A, pab 103-PA03 200 150 104
human sTIE-1/Fc Chimera SFC-012 100 285 94 anti-mouse VEGF-A, pab 103-PA03AG 50 175 104
anti-human TIE-1 (#6F12), mab 101-M48 100 230 94 anti-mouse VEGF-A, pab 103-P36 100 270 104
anti-human TIE-1 (#6F12) Biotin, mab 101-MBi48 50 230 94 anti-human VEGF-A (#3), mab 101-M59 100 230 104
anti-human TIE-1 (#8C9), mab 101-M46 100 230 94 anti-human VEGF-A (#3C5), mab 101-M56 100 230 104
mouse sTIE-1/Fc Chimera SFC-031 20 100 94 anti-human VEGF-A (#7G7), mab 101-M58 100 230 104
mouse sTIE-1/Fc Chimera SFC-032 100 285 94 human VEGF-A BIOLISA (active) DA-066 96-well 395 103
human sTIE-2/Fc Chimera SFC-013 20 100 94 human VEGF-A ELISA (total) DA-068 96-well 395 102
human sTIE-2/Fc Chimera SFC-014 100 285 94 mouse VEGF-A ELISA (total) DA-072 96-well 375 103
anti-human TIE-2 (#tek2), mab 101-M50 100 230 95 rat VEGF-C R20-014 5 95 104
anti-human TIE-2 (#tek2) Biotin, mab 101-MBi50 50 230 95 rat VEGF-C R20-015 20 220 104
anti-human TIE-2 (#tek9), mab 101-M52 100 230 95 anti-rat VEGF-C, pab 104-PA10S 100 150 106
anti-human TIE-2 (#tek9) Biotin, mab 101-MBi52 50 230 95 anti-rat VEGF-C, pab 104-PA10 200 225 106
anti-human TIE-2 (#tek16), mab 101-M54 100 230 95 human VEGF-C ELISA (total) DA-070 96-well 395 105
anti-human TIE-2 (#tek16) Biotin, mab 101-MBi54 50 230 95 rat VEGF-C ELISA (total) DA-074 96-well 395 105
mouse sTIE-2/Fc Chimera SFC-033 20 100 95 rat VEGF-C152S R20-016 5 90 105
mouse sTIE-2/Fc Chimera SFC-034 100 285 95 rat VEGF-C152S R20-017 20 195 105
human TL-1A 100-294 20 210 95 anti-rat VEGF-D, pab 104-PA12S 100 150 106
human TNF-alpha 300-027 10 55 96 anti-rat VEGF-D, pab 104-PA12 200 225 106
human TNF-alpha 300-028 50 135 96 orf-virus VEGF-E 300-044S 2 80 106
anti-human TNF-alpha, mab 101-M17 500 250 96 orf-virus VEGF-E 300-044 5 160 106
anti-human TNF-alpha, pab 102-P87 100 270 96 orf-virus VEGF-E 300-045 20 490 106
mouse TNF-alpha M10-041 20 210 96 orf-virus HB-VEGF-E 300-046S 5 160 107
anti-mouse TNF-alpha, pab 103-P35 100 270 96 orf-virus HB-VEGF-E 300-046 20 490 107
anti-mouse TNF-alpha, pab 103-P35G 100 270 96 human sVEGFR-1/Flt-1 (native) S01-009 5 50 107
rat TNF-alpha R20-013 20 210 96 human sVEGFR-1/Flt-1 (native) S01-010 20 140 107
anti-rat TNF-alpha, pab 104-P11 100 270 96 human sVEGFR.1/Flt-1 (D5) S01-011 5 50 107
human sTNF receptor type I 100-118 20 210 97 human sVEGFR.1/Flt-1 (D5) S01-012 20 140 107
anti-human TNF receptor type I, pab 102-P95 100 270 97 human sVEGFR.1/Flt-1 (D4) S01-013 5 125 108
human sTNF receptor type II 100-119 20 210 97 human sVEGFR.1/Flt-1 (D4) S01-014 20 240 108
anti-human TNF receptor type II, pab 102-P96 100 270 97 human sVEGFR.1/Flt-1 (D3) S01-015 5 125 108
human TNF-beta 100-108 20 210 96 human sVEGFR.1/Flt-1 (D3) S01-016 20 240 108
human TNF-beta 100-297 20 210 96 human sVEGFR-1(D7)-Fc Chimera SFC-005 10 75 108
anti-human TNF-beta, pab 102-P88 100 270 97 human sVEGFR-1(D7)-Fc Chimera SFC-006 50 235 108
human TPO 100-109S 2 55 98 anti-human VEGFR-1/Flt-1 (#EWC), mab 101-M24 100 250 109
human TPO 100-109 10 135 98 anti-human VEGFR-1/Flt-1 (#EIC), mab 101-M26 100 250 109
human TPO 100-109-SC 50 395 98 anti-human VEGFR-1/Flt-1 (#EWF), mab 101-M28 100 230 109
anti-human TPO, pab 102-P89 100 270 98 anti-human VEGFR-1 (#EWF), Biotin, mab 101-MBi28 50 230 109
mouse TPO M10-087 10 270 98 anti-human VEGFR-1/Flt-1 (#EWI), mab 101-M30 100 230 109
human sTRAIL R-1/DR4 S01-035 50 210 99 anti-human VEGFR-1/Flt-1, pab 102-PA20S 100 150 109
human sTRAIL R-2/DR5 S01-036 50 210 99 anti-human VEGFR-1/Flt-1, pab 102-PA20 200 225 109
human sTRAIL/Apo2L 100-301 50 210 98 human VEGFR-1 ELISA (total) DA-064 96-well 395 109
anti-human TRAIL/Apo2L, mab 101-M86 500 250 98 human sVEGFR-2/KDR (D7) S01-001 5 50 110
anti-human TRAIL/Apo2L, pab 102-P97 100 270 98 human sVEGFR-2/KDR (D7) S01-002 20 300 110
human TSLP 100-304 10 210 99 human sVEGFR-2/KDR-Fc Chimera SFC-007 10 75 110
human TWEAK 100-111 50 210 99 human sVEGFR-2/KDR-Fc Chimera SFC-008 50 235 110
anti-human TWEAK, pab 102-P90 100 270 100 anti-human VEGFR-2/KDR (#3), mab 101-M32 100 230 111
human sTWEAK receptor S01-037 25 210 100 anti-human VEGFR-2 (#3) Biotin, mab 101-MBi32 50 230 111
anti-human TWEAK receptor, pab 102-P98 100 270 100 anti-human VEGFR-2/KDR (#4), mab 101-M34 100 230 111
human VEGF 121 300-031S 2 80 100 anti-human VEGFR-2/KDR (#EIC), mab 101-M20 100 250 111
human VEGF 121 300-031 5 160 100 anti-human VEGFR-2 (#EIC) Biotin, mab 101-MBi20 50 250 111
human VEGF 121 300-032 20 490 100 anti-human VEGFR-2/KDR (#EWC), mab 101-M22 100 250 111
human VEGF 121 300-071S 2 70 100 anti-human VEGFR-2/KDR, pab 102-PA18 200 195 110
human VEGF 121 300-071 5 120 100 anti-human VEGFR-2/KDR, pab 102-PA19S 100 150 110
human VEGF 121 300-072 20 350 100 anti-human VEGFR-2/KDR, pab 102-PA19 200 225 110
human VEGF 145 300-033S 2 70 101 anti-human VEGFR-2/KDR, pab 102-PA19AG 50 175 110
human VEGF 145 300-033 5 130 101 anti-human VEGFR-2/sc-Fv, single chain 500-001 100 250 111
human VEGF 145 300-034 20 300 101 human sVEGFR-3/FLT-4 S01-017 10 140 112
mouse VEGF164 M30-001S 2 70 101 human sVEGFR-3/FLT-4 S01-018 50 300 112
mouse VEGF164 M30-001 5 130 101 human sVEGFR-3/Fc Chimera SFC-009 10 95 112
mouse VEGF164 M30-002 20 300 101 human sVEGFR-3/Fc Chimera SFC-010 50 265 112
mouse VEGF164 M10-043 10 210 101 anti-human VEGFR-3/FLT-4, pab 102-PA22AG 100 250 112
human VEGF 165 300-035S 2 70 102 anti-human VEGFR-3/FLT-4, pab 102-PA23S 100 150 112
human VEGF 165 300-035 5 130 102 anti-human VEGFR-3/FLT-4, pab 102-PA23 200 225 112
human VEGF 165 300-036 20 300 102 anti-human VEGFR-3/FLT-4, pab 102-PA23AG 50 175 112
human VEGF 165 300-075S 2 60 102 anti-human VEGFR-3/FLT-4, mab 101-M36 100 250 112
human VEGF 165 300-075 5 100 102
human VEGF 165 300-076 20 260 102
anti-human VEGF-A, pab 102-P91 100 270 104
anti-human VEGF-A, pab 102-P91G 100 270 104
anti-human VEGF-A, pab 102-PA02S 100 150 104

 

Send mail to webmaster@gentaur.com with questions or comments about this web site.
Copyright © 2002 GENTAUR Molecular Products
Last modified: 05/29/09